... Shenzhen, China.3Department of Surgery, University of Western Ontario, London, Ontario,Canada.4Department of Medicine, Division of Neurosurgery, University of California San Diego, San Diego, ... was 4 years with no evidence of immune reac-tivity or GVHD. Evaluation of therapeutic benefit is cur-rently in progress.Author details1Nanshan Affiliated Hospital of Guangdong Medical College, ... immunologically-mediated adverse effects of allo-geneic cord bloo d therapy in absence of i mmune sup-pression/mye loablation. This study presents for the firsttime a detailed safety analysis of using non-matched,allogeneic...